Skip to content
CancerIndex

Publication

Reassessing the role of CEA in the treatment of rectal cancer in the era of TNT.

M Diefenhardt, R-D Hofheinz, M Fleischmann, A Schlenska-Lange, R Grützmann, S Kirste, T Kuhnt, R Kosmala, C Rödel, A Wiegering, M Ghadimi, C Gani, E Fokas, D Martin

ESMO gastrointestinal oncologySep 1, 2026PMID 42582989doi:10.1016/j.esmogo.2026.100355 PMC13459590Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 10, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260910-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Measurement of carcinoembryonic antigen (CEA) is an integral part of surveillance strategies in rectal cancer. We evaluated the prognostic significance of CEA level before total neoadjuvant therapy (TNT) and its role in surveillance strategies after TNT. PATIENTS AND METHODS: This post…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.